Skip to main content

Table 1 Sample characteristics (N = 268)

From: Screening for cognitive symptoms in dialysis patients with an extended version of Kidney Disease Quality of Life Cognitive Function subscale (KDQOL-CF): a validation study

 

Mean (SD) / N (%)

Sociodemographic

 

Gender

 

Male

154 (57.5%)

Female

114 (42.5%)

Age (years)

59.87 (11.72)

Ethnicity

 

Chinese

151 (56.3%)

Malay

80 (29.9%)

Indian or others

37 (13.8%)

Highest education

 

Primary or lower

65 (24.9%)

Secondary

132 (50.6%)

Post-secondary or higher

64 (24.5%)

Relationship status

 

In a relationship

182 (67.9%)

Not in a relationship

86 (32.1%)

Work status

 

Working

76 (28.5%)

Not working

191 (71.5%)

Clinical

 

Primary diagnosis

 

Diabetic nephropathy

122 (45.5%)

Glomerulonephritis

49 (18.3%)

Hypertension

36 (13.4%)

IgA nephropathy

12 (4.5%)

Others/uncertain aetiology

49 (18.3%)

Presence of diabetes

145 (54.3%)

Presence of hypertension

232 (86.9%)

Presence of hyperlipidaemia

143 (53.6%)

Presence of cardiovascular disease

141 (52.8%)

Duration on HD (months)

78.85 (62.80)

Medication count

12.76 (4.25)

Dialysis adequacy (Kt/V)

1.60 (0.24)

Cognitive

 

MoCA

21.49 (4.29)

Range: 9–30

PAOFI

1.99 (0.70)

Range: 1.00-5.39

Original KDQOL-CF

82.54 (17.81)

Range: 0-100

Extended KDQOL-CF

81.90 (16.72)

Range: 5-100

  1. Notes. N = Sample size. SD = Standard Deviation. HD = Haemodialysis. MoCA = Montreal Cognitive Assessment. PAOFI = Patient’s Assessment of Own Functioning Inventory. KDQOL-CF = Kidney Disease Quality of Life Cognitive Function subscale